Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 070629/0798 | |
| Pages: | 9 |
| | Recorded: | 03/26/2025 | | |
| Attorney Dkt #: | 2699563 JD PT3 |
| Conveyance: | SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18935127
|
Filing Dt:
|
11/01/2024
|
|
Publication #:
|
|
Pub Dt:
|
05/29/2025
| | | | |
|
Title:
|
ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18958759
|
Filing Dt:
|
11/25/2024
|
|
Publication #:
|
|
Pub Dt:
|
03/13/2025
| | | | |
|
Title:
|
Solid Dispersion Forms of Rifaximin
|
|
|
Assignee
|
|
|
|
|
| 240 GREENWICH STREET |
| NEW YORK, NEW YORK 10286 |
|
|
Correspondence name and address
|
| |
JAY DASILVA
|
| |
1025 CONNECTICUT AVENUE NW
|
| |
SUITE 712
|
| |
WASHINGTON, DC 20036
|
Search Results as of:
08/09/2025 05:09 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
